Journal of Medical Virology
Overview
The Journal of Medical Virology is a peer-reviewed scientific journal that publishes cutting-edge research on all aspects of medical virology. It covers a wide range of topics including viral pathogenesis, epidemiology, diagnostics, antiviral therapies, and vaccine development. With a focus on human viral infections, this journal serves as a valuable resource for virologists, clinicians, and researchers in the field of infectious diseases.
Details
Details
Abbr.
J Med Virol
Start
1977
End
Continuing
Frequency
Monthly
p-ISSN
0146-6615
e-ISSN
1096-9071
Country
United States
Language
English
Specialty
Microbiology
Metrics
Metrics
h-index / Ranks: 1339
154
SJR / Ranks: 1845
1560
CiteScore / Ranks: 248
23.40
JIF / Ranks: 302
12.7
Recent Articles
1.
2.
Zhang X, Wu S, Lin Y, Zhang W, Zhang Y, Li X, et al.
J Med Virol
. 2025 Mar;
97(3):e70295.
PMID: 40088087
HIV-1 establishes a stable latent reservoir in host cells such as CD4 T lymphocytes, which cannot be recognized by the immune system. Accurately assessing the active latent reservoir by HIV-1...
3.
Botello-Marabotto M, Tarraso J, Mulet A, Presa-Fernandez L, Fernandez-Fabrellas E, Portal J, et al.
J Med Virol
. 2025 Mar;
97(3):e70289.
PMID: 40088077
Coronavirus disease 2019 (COVID-19) global pandemic has affected more than 600 million people up to date. The symptomatology and severity of COVID-19 are very broad, and there are still concerns...
4.
5.
Karunaithas S, Chaibun T, Chatchawal P, Promptmas C, Buajeeb W, Yin L, et al.
J Med Virol
. 2025 Mar;
97(3):e70299.
PMID: 40071579
Human papillomavirus type 16 (HPV-16) is a key driver in the development of cervical carcinoma, with the integration of its genome into the host DNA marking a critical step in...
6.
Liu H, Lin S, Ramirez R, Chen S, Heimer Z, Kubas R, et al.
J Med Virol
. 2025 Mar;
97(3):e70290.
PMID: 40062878
This study characterized a hepatitis B virus (HBV) hybridization-capture next-generation sequencing (HBV-NGS) assay and applied it to develop a model for estimating the integrated HBV DNA (iDNA) quantity and for...
7.
Azanza J, Gonzalez Del Castillo J, Ferrando R, Molero J, Soriano A, Peral C, et al.
J Med Virol
. 2025 Mar;
97(3):e70288.
PMID: 40062871
The objective was to estimate the cost-effectiveness of nirmatrelvir/ritonavir (NMV/r) in treating adults with COVID-19 at high-risk of developing severe COVID-19 who do not require supplemental oxygen, compared to no...
8.
Xie Z, Tan W, Wang Z, Kang Y, Zhang M, Li W, et al.
J Med Virol
. 2025 Mar;
97(3):e70284.
PMID: 40062428
Although hepatitis B virus (HBV) infection is a well-documented etiologic factor for hepatocellular carcinoma (HCC), which ranks as the third leading cause of cancer-related mortality globally, the mechanism by which...
9.
Liu S, Liu P, Lu Q, Shen Y, Zhang L, Liang Z, et al.
J Med Virol
. 2025 Mar;
97(3):e70242.
PMID: 40062404
The emergence of Omicron variants dramatically changed the transmission rate and infection characteristics compared to previously prevalent strains, primarily due to spike protein mutations. However, the impact of individual mutations...
10.
COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based Approach
Garcia-Vidal C, Teijon-Lumbreras C, Aiello T, Chumbita M, Menendez R, Subira A, et al.
J Med Virol
. 2025 Mar;
97(3):e70276.
PMID: 40059457
Conflicting results from randomized trials regarding the efficacy of remdesivir for COVID-19 have been reported. We aimed to develop a neural network (NN) to identify COVID-19 patients who would derive...